HRP20000496A2 - Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers - Google Patents
Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers Download PDFInfo
- Publication number
- HRP20000496A2 HRP20000496A2 HR20000496A HRP20000496A HRP20000496A2 HR P20000496 A2 HRP20000496 A2 HR P20000496A2 HR 20000496 A HR20000496 A HR 20000496A HR P20000496 A HRP20000496 A HR P20000496A HR P20000496 A2 HRP20000496 A2 HR P20000496A2
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- pyridone
- hydroxy
- use according
- residue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19802708A DE19802708A1 (de) | 1998-01-24 | 1998-01-24 | Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren |
| PCT/EP1999/000105 WO1999037300A1 (de) | 1998-01-24 | 1999-01-11 | Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20000496A2 true HRP20000496A2 (en) | 2000-12-31 |
Family
ID=7855595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20000496A HRP20000496A2 (en) | 1998-01-24 | 1999-01-11 | Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6534528B1 (https=) |
| EP (1) | EP1049468B1 (https=) |
| JP (1) | JP5127091B2 (https=) |
| KR (1) | KR100597332B1 (https=) |
| CN (1) | CN1128619C (https=) |
| AR (1) | AR016445A1 (https=) |
| AT (1) | ATE360418T1 (https=) |
| AU (1) | AU752406B2 (https=) |
| BR (1) | BR9907734A (https=) |
| CA (1) | CA2319359C (https=) |
| CY (1) | CY1106684T1 (https=) |
| DE (2) | DE19802708A1 (https=) |
| DK (1) | DK1049468T3 (https=) |
| ES (1) | ES2285829T3 (https=) |
| HR (1) | HRP20000496A2 (https=) |
| HU (1) | HU228824B1 (https=) |
| IL (1) | IL137453A (https=) |
| ME (1) | ME00390B (https=) |
| NZ (1) | NZ505898A (https=) |
| PL (1) | PL192550B1 (https=) |
| PT (1) | PT1049468E (https=) |
| RS (1) | RS50903B (https=) |
| RU (1) | RU2212239C2 (https=) |
| SI (1) | SI1049468T1 (https=) |
| SK (1) | SK285350B6 (https=) |
| TR (1) | TR200002118T2 (https=) |
| WO (1) | WO1999037300A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001122804A (ja) * | 1999-10-28 | 2001-05-08 | Sato Pharmaceutical Co Ltd | リン酸コーンスターチ配合外用医薬組成物 |
| EP1354586A1 (en) * | 2002-04-20 | 2003-10-22 | Aventis Pharma Deutschland GmbH | The use of hydroxpyridone-derivatives in wound healing |
| US20060257439A1 (en) * | 2005-03-29 | 2006-11-16 | Sabnis Ram W | Cleansing compositions with color changing indicator |
| RU2326665C1 (ru) * | 2007-04-03 | 2008-06-20 | Марвел ЛайфСайнсез Лимитед, Великобритания | Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием |
| MX2013001095A (es) * | 2010-07-27 | 2013-03-12 | Clariant Finance Bvi Ltd | Composiciones que comprenden peroxido de hidrogeno o sustancias donadoras de peroxido de hidrogeno. |
| ES2525388T3 (es) * | 2010-07-27 | 2014-12-23 | Clariant Finance (Bvi) Limited | Utilización de hidroxipiridonas o de sus sales para la estabilización del peróxido de hidrógeno o de unas sustancias que ponen en libertad peróxido de hidrógeno |
| RS61907B1 (sr) | 2015-04-06 | 2021-06-30 | Subdomain Llc | Polipeptidi koji sadrže de novo vezujući domen i njihova primena |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2540218A (en) | 1947-08-25 | 1951-02-06 | Squibb & Sons Inc | 2-hydroxy-pyridine-n-oxide and process for preparing same |
| EP0241918B1 (de) * | 1986-04-18 | 1992-05-27 | Hoechst Aktiengesellschaft | 1-Hydroxy-2-pyridone, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten, sowie bei der Herstellung der 1-Hydroxy-2-pyridone gebildete Zwischenprodukte |
| JPS63264504A (ja) * | 1987-04-17 | 1988-11-01 | Shinto Paint Co Ltd | 工業用防カビ組成物 |
| US4956184A (en) * | 1988-05-06 | 1990-09-11 | Alcide Corporation | Topical treatment of genital herpes lesions |
| CA2046801C (en) * | 1990-08-07 | 2002-02-26 | Peter D. Davis | Substituted pyrroles |
| DE4333893A1 (de) * | 1993-10-05 | 1995-04-06 | Hoechst Ag | Kosmetische Zubereitungen |
| DE59609219D1 (de) * | 1995-12-04 | 2002-06-20 | Aventis Pharma Gmbh | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen |
-
1998
- 1998-01-24 DE DE19802708A patent/DE19802708A1/de not_active Withdrawn
-
1999
- 1999-01-11 ME MEP-2008-559A patent/ME00390B/me unknown
- 1999-01-11 WO PCT/EP1999/000105 patent/WO1999037300A1/de not_active Ceased
- 1999-01-11 HR HR20000496A patent/HRP20000496A2/hr not_active Application Discontinuation
- 1999-01-11 TR TR2000/02118T patent/TR200002118T2/xx unknown
- 1999-01-11 AT AT99902528T patent/ATE360418T1/de active
- 1999-01-11 EP EP99902528A patent/EP1049468B1/de not_active Expired - Lifetime
- 1999-01-11 DE DE59914312T patent/DE59914312D1/de not_active Expired - Lifetime
- 1999-01-11 NZ NZ505898A patent/NZ505898A/en not_active IP Right Cessation
- 1999-01-11 RU RU2000122313/14A patent/RU2212239C2/ru active
- 1999-01-11 RS YUP-437/00A patent/RS50903B/sr unknown
- 1999-01-11 DK DK99902528T patent/DK1049468T3/da active
- 1999-01-11 SK SK1089-2000A patent/SK285350B6/sk not_active IP Right Cessation
- 1999-01-11 IL IL13745399A patent/IL137453A/xx not_active IP Right Cessation
- 1999-01-11 PL PL342055A patent/PL192550B1/pl unknown
- 1999-01-11 AU AU22787/99A patent/AU752406B2/en not_active Expired
- 1999-01-11 PT PT99902528T patent/PT1049468E/pt unknown
- 1999-01-11 ES ES99902528T patent/ES2285829T3/es not_active Expired - Lifetime
- 1999-01-11 CA CA002319359A patent/CA2319359C/en not_active Expired - Lifetime
- 1999-01-11 JP JP2000528282A patent/JP5127091B2/ja not_active Expired - Lifetime
- 1999-01-11 BR BR9907734-5A patent/BR9907734A/pt not_active Application Discontinuation
- 1999-01-11 HU HU0200851A patent/HU228824B1/hu unknown
- 1999-01-11 SI SI9930962T patent/SI1049468T1/sl unknown
- 1999-01-11 US US09/600,903 patent/US6534528B1/en not_active Expired - Lifetime
- 1999-01-11 KR KR1020007008050A patent/KR100597332B1/ko not_active Expired - Lifetime
- 1999-01-11 CN CN99802327A patent/CN1128619C/zh not_active Expired - Lifetime
- 1999-01-21 AR ARP990100243A patent/AR016445A1/es unknown
-
2007
- 2007-06-28 CY CY20071100855T patent/CY1106684T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002087563A3 (en) | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions | |
| JP2010077143A (ja) | 創傷治療用外用剤 | |
| TR200101903T2 (tr) | Yeni malonik asit türevleri, bunların preparasyon işlemleri. | |
| JP2018525348A (ja) | 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用 | |
| CZ254197A3 (cs) | Multifunkční enzym | |
| CN100420439C (zh) | 双胍衍生物在制备具有瘢痕形成作用的医药产品中的应用 | |
| GB2048070A (en) | Medication for Open Wounds | |
| JP6169693B2 (ja) | 次亜塩素酸およびアミノ酸を含む創傷およびびらんを治療するための製剤 | |
| HRP20000496A2 (en) | Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers | |
| EP2570124B1 (en) | Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics | |
| RS55672B1 (sr) | Supstance oleuropeina za lečenje rana i čireva kod starijih ljudi i/ili dijabetičara | |
| CZ295316B6 (cs) | Léčivo k léčbě bércových vředů a proleženin | |
| MXPA00007000A (en) | Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers | |
| HK1034447B (en) | Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers | |
| RU2122401C1 (ru) | Ранозаживляющая композиция | |
| JPH04208219A (ja) | 褥瘡及び皮膚潰瘍治療外用剤 | |
| JP2007277135A (ja) | 創傷治療用外用剤 | |
| WO2007084127A1 (en) | Use of gluten for wound treatment as active healing ingredient | |
| Steenvoorde et al. | An unexpected effect of Dermacyn on infected leg ulcers | |
| JPWO1996033733A1 (ja) | 新規な皮膚欠損症治療剤 | |
| JPH0489426A (ja) | 褥瘡及び皮膚潰瘍治療用乳剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| PNAN | Change of the applicant name, address/residence |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE |
|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20081231 Year of fee payment: 11 |
|
| ODBI | Application refused |